High-intensity cardiorespiratory and strength exercises reduced emotional distress and fatigue in patients with axial spondyloarthritis: a randomized controlled pilot study.

Autor: Sveaas, SH, Berg, IJ, Fongen, C, Provan, SA, Dagfinrud, H

Publikováno v: Scandinavian Journal of Rheumatology; Mar2018, Vol. 47 Issue 2, p117-121, 5p, 1 Diagram, 2 Charts

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis

Autor: I. B. Wilkinson, Tore K Kvien, I.K. Eeg, Eirik Ikdahl, A. Mathiessen, Sella Aarrestad Provan, Silvia Rollefstad, Nina Østerås, Anne Grete Semb, Ida K. Haugen, C. M. McEniery, Inger Jorid Berg, Hilde Berner Hammer

Publikováno v: BMC Rheumatology
BMC Rheumatology, Vol 3, Iss 1, Pp 1-9 (2019)

Background The objective of this study was to explore the associations between ultrasonographic and radiographic joint scores and levels of arterial CVD risk markers in patients with osteoarthritis (OA). Secondly, to compare the levels of arterial CV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f44c87e8c6edc2b630619ab71505f5
https://pubmed.ncbi.nlm.nih.gov/31410391

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.

Autor: Wolf AS; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: asia-sophia.wolf@fhi.no., Bjørlykke KH; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ørbo HS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Bhandari S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Solum G; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kjønstad IF; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Jyssum I; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Nygaard UC; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kristoffersen AB; Division of Infection Control, Section for Modelling and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway., Christensen IE; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Josefsson SE; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Lund KP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Chopra A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Osen JR; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Chaban V; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Tveter AT; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Kvien TK; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jahnsen J; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Haavardsholm EA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Grødeland G; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Vaage JT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Section for Public Health, Inland Norway University of Applied Sciences, Norway., Kared H; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Lund-Johansen F; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Munthe LA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway. Electronic address: Kristin.Kaasen.Jorgensen@ahus.no., Mjaaland S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.

Publikováno v: EBioMedicine [EBioMedicine] 2024 Oct; Vol. 108, pp. 105317. Date of Electronic Publication: 2024 Sep 10.

Participatory Development of a Virtual Reality Exercise Program for People with Chronic Pain.

Autor: Provan SA; Department of Public Health and Sport Sciences, Faculty of Social and Health Sciences, Inland Norway University of Applied Sciences, Elverum, Norway.; Department of Rheumatology, Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Litleskare S; Department of Public Health and Sport Sciences, Faculty of Social and Health Sciences, Inland Norway University of Applied Sciences, Elverum, Norway., Flaten OE; Game School-Department of Game Development, Inland Norway University of Applied Sciences, Hamar, Norway., Pettersen H; Department of Rheumatology, Department of Social Work and Guidance, Faculty of Health and Social Sciences, Inland Norway University of Applied Sciences, Lillehammer, Norway., Røset L; Department of Public Health and Sport Sciences, Faculty of Social and Health Sciences, Inland Norway University of Applied Sciences, Elverum, Norway., Calogiuri G; Department of Public Health and Sport Sciences, Faculty of Social and Health Sciences, Inland Norway University of Applied Sciences, Elverum, Norway.; Department of Nursing and Health Sciences, Centre for Health and Technology, University of South-Eastern Norway, Drammen, Norway.

Publikováno v: Games for health journal [Games Health J] 2024 Oct; Vol. 13 (5), pp. 332-334. Date of Electronic Publication: 2024 Apr 01.

Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022.

Autor: Moe SR; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Haukeland H; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Rheumatology, Martina Hansens Hospital, Gjettum, Norway., Brunborg C; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Botea A; Department of Rheumatology, Betanien Hospital, Skien, Norway., Damjanic N; Department of Rheumatology, Martina Hansens Hospital, Gjettum, Norway., Wivestad GÅ; Division of Rheumatology, Department of Medicine, Hospital of Southern Norway Trust, Kristiansand, Norway., Øvreås H; Department of Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway., Bøe T; Department of Internal Medicine, Vestfold Hospital Trust, Tonsberg, Norway., Orre A; Department of Rheumatology, Vestre Viken Hospital Trust, Drammen, Norway., Garen T; Department of Rheumatology, Oslo University Hospital, Oslo, Norway., Lilleby V; Department of Rheumatology, Oslo University Hospital, Oslo, Norway., Provan SA; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Section for Public Health, Innland Norway University of Applied Sciences, Hamar, Norway., Molberg Ø; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lerang K; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Aug 01; Vol. 63 (8), pp. 2109-2117.